August 29, 2012
Is your memory loss a sign of aging? Or something else…Research for People with Mild Cognitive Impairment and Early Alzheimer’s
NeuroTrials Research specializes in clinical trials for a variety of neurological and sleep disorders. Frequent research includes Alzheimer’s disease and other forms of cognitive impairment.
We are currently enrolling for a clinical trial for individuals with Mild Cognitive Impairment or early Alzheimer’s disease – details are described below. If you or someone you know may qualify, please contact us at (404) 851-9934. Help us research solutions for Alzheimer’s!
Mild Cognitive Impairment or Mild Alzheimer’s Sleep Research Study
This is a 7 week study to examine an investigational cognitive enhancement drug and its effect on sleep quality in volunteers with mild cognitive impairment or early Alzheimer’s disease. Compensation is available for the patient and the study partner.
- Age 50-85
- Have Mild Cognitive Impairment or early Alzheimer’s disease
- No other major neurological disorders or history of stroke
- Good general health with no unstable conditions
- Patient must have a “study partner”, which may be a caregiver, family member, or friend who visits with them regularly. The study partner must be capable and willing to accompany the patient to the first visit and additional visits as needed.
To learn more about this study, visit our study page.
We also have new research studies opening up throughout the year. For more information about this study, or to be included in our patient database for future studies, please contact us at (404) 851-9934, or visit us at www.neurotrials.com.
February 2, 2012
In Bonita Springs, FL a group of Parkinson’s patients and their caregivers come together once per week to dance. While show tunes or Broadway music plays, patients and caregivers do improv moves, ballet techniques, and partner dancing.
The exercise helps to hold back muscle problems that are commonly associated with Parkinson’s Disease. For many people, a diagnosis of Parkinson’s Disease comes as a shock, since symptoms are usually first passed off as a consequence of aging. In addition to decreased motor skills due to Parkinson’s, there are other difficulties a person may not notice at first. Bradykinesia, which slows down movements, and swallowing and speaking can prove more difficult over time.
Currently, there is no definite cure for Parkinson’s disease, which has an estimated 50,000 confirmed cases in the United States. The symptoms of the disease usually occur after the age of 50. However, there are some famous examples of early onset cases. Both actor Michael J Fox, diagnosed in his 30s, and current Texas A&M basketball coach Billy Kennedy, 47, have been open about their early onset, bringing a much needed spotlight to the cause.
As for the dancers, one patient believes the exercise is helping. “All the medications deal with the symptoms of the disease, but there is no cure. We have worked through the disease for 20 years, and I feel there is no better way to retard the progress of the disease than regular exercise,” said Chuck McEwen after a dance class.
Learn more about a new Parkinson’s research study in Atlanta. Another Parkinson’s study is currently pending.
December 5, 2011
While most sleep physicians have long suspected a connection between RLS and genetics, researchers have not been able to definitively find the link.
A new study, however, has discovered two faulty genes that cause restless leg syndrome. People who inherited the mutations are much more likely to develop restless leg syndrome
The discovery sheds light on the origins of one of the most common nerve disorders, and could pave the way for new drugs to help sufferers.
Around one in 10 adults experiences restless leg syndrome at some point in their life. Sufferers experience unpleasant sensations in their legs which can only be eased by moving, walking or jiggling.
The new study looked at the genetic make-up of 4,867 volunteers with RLS and compared them to more than 7,000 individuals without the syndrome. Scientists found two new areas on the genome which play a role. One area is within a gene involved in controlling brain activity called TOX3.
TOX3 is involved in protecting brain cells – but its link to restless leg syndrome is still unknown. However, the discoveries could lead to new treatments for the condition.
While the sleep disorder most commonly affects legs, it can also be experienced in the arms or torso. The constant need to move causes patterns of interrupted or restless sleep. More than 5 million Americans suffer from RLS.
NeuroTrials Research, will soon be conducting a new research study on RLS. This research is groundbreaking as it involves an entirely new drug class for individuals suffering from RLS. For more information on the study,visit the study page.
July 18, 2011
Do you or someone you know suffer from Parkinson’s Disease?
An estimated 7 to 10 million people worldwide live with Parkinson’s disease. The disease affects men and women equally, and 4% of those with Parkinson’s are diagnosed before they turn 50. Read on for tips on living with Parkinson’s.
- Take advantage of technology to keep your life simple. If mobility is a problem, invest in a good walking cane or wheelchair. Use items such as button hooks, telephones with large buttons, and utensils with oversized handles to cut down the hassle factor associated with every day occurences.
- Steal a pro athlete’s secret trick. Many professional athletes will visualize making the game winning shot, pass, or putt before stepping onto the field. When dealing with Parkinson’s, it may take you several attempts to do something such as getting up from chair. Rather than letting stress enter your mind, visualize your task before you do it. You are likely to be more sucessful.
- Stay flexible. Stretching your muscles helps you gain control. For a list of simple stretching exercises, check out this link.
- Maintain a healthy body weight. If you are overweight, losing weight can help your body adjust quicker to movement-related issues and can help muscles adjust to the extra demands of the disease.
- Always plan ahead. If you are traveling, plan on arriving at the airport early to navigate safely through security. If on vacation, plan fit ample time to rest into your flurry of activities.
New Research Opportunity
NeuroTrials Research is conducting a study on the efficacy of a new study drug for patients with moderate to severe Parkinson’s Disease. Qualified participants may receive compensation for time and travel as well as study drug and examinations at no cost.
You may qualify if you:
- are 30 to 85
- are in general good health
- experience slowness in movement
- experience muscle rigidity or resting tremors
- have been on a stable dose of L-Dopa for over 1 year.
Participate in research, find out how you can help
. Call us today at 404-851-9934 or visit www.neurotrials.com
April 26, 2011
What do your dreams have to do with your likelihood of developing Parkinson’s Disease?
A new study from Denmark’s Center for Healthy Aging and the Danish Center for Sleep Medicine, among other places, suggests that people likely to develop Parkinson’s might first show signs in their sleep pattern.Researchers found that one of the earliest symptoms of Parkinson’s may be a REM sleep disorder known as REM Sleep Behavior Disorder.
With REM Sleep Behavior Disorder, individuals tend to act out their dreams. The dreams are usually unpleasant, and the person will kick, scream, punch, or grab.
The active dreaming can appear up to eight years before other symptoms of Parkinson’s. If researchers are able to find enough evidence to support this link, they can help patients identify the disease before it becomes too severe.
January 27, 2011
Did you know twenty million people experience occasional sleep problems each year?
The Atlanta Sleep Medicine Clinic recently posted on Healthy People 2020 & the government’s decision to include sleep health in their report on national health objectives and goals. As sleep health awareness continues to grow, many people are beginning to seek medical help in dealing with their sleep problems.
You may be familiar with CPAP therapy for sleep apnea patients as well as the variety of medications available for insomnia or narcolepsy. But what if, instead of taking a pill, you could drink your sleep aid?
NeuroTrials Research is currently conducting a clinical research study to evaluate the effectiveness of a sleep drink for those with poor sleep quality. The study requires only 3 in-office visits and qualified participants may be compensated for time and travel.
If you are generally a good sleeper but have been experiencing unsatisfactory sleep for 2-3 nights throughout the past month you may qualify to participate in this study. Participants must be between 25-65 years of age and cannot work a night shift.
For more information on this study, call 404-851-9934 or visit NeuroTrials.
December 8, 2010
For the first time since its creation in 1979, the government’s report on health objectives and goals over the next decade includes Alzheimer’s disease. Known as Healthy People 2020, the report was developed through a broad consultation process and built on the best scientific knowledge available. It is designed to be used by states, communities, professional organizations, and others to assit in developing programs that improve our nation’s health.
Alzheimer’s is the sixth-leading cause of death in our nation and more than 5 million Americans are currently diagnosed with the disease. Because the risk of Alzheimer’s expands with age, as many as 16 million Americans are expected to be diagnosed with Alzheimer’s by 2050. With goals set through Healthy People 2020, many are hoping that projection will decrease.
The report includes objectives such as increasing education about the disease and increasing the awareness of the diagnosis to those with Alzeheimer’s or their caregivers. According to the American Alzheimer’s Association, fewer than half of patients with Alzheimer’s have the diagnosis listed on their medical records.
Healthy People 2020 also establishes a goal of reducing the number of preventable hospitalizations for those with Alzheimer’s by preventing the conditions that cause admittance and optimizing outpatient care.
If you or someone you know has been diagnosed with Alzheimer’s disease, and live near the Atlanta area, consider participating in NeuroTrials Research’s clinical research study. We are currently evaulating an investigational drug for Alzheimer’s. You may be eligible to participate if you are 50 years or older and have a diagnosis of mild to moderate Alzheimer’s. For more information visit our studies page or call us at (404) 851-9934.
Why Participate in A Clinical Trial?
According to the national Alzheimer’s Association, “through clinical trials, researchers test new ways to detect, treat and prevent Alzheimer’s disease and related dementias. Without clinical trials, there can be no new treatments or cures. Over the last 15 years, scientists have made enormous strides in understanding how Alzheimer’s disease affects the brain. Scientists believe that in the near future, therapies and treatments that slow or stop the progression of the disease will be available.Ground-breaking research is going on that could have a measurable impact on the lives of current and future Alzheimer patients. Participation in clinical studies provides an opportunity to advance and accelerate medical research and to contribute to the better health of future generations.”